Skip to content

Treatment of Psoriasis by Unani Medicines

Efficacy of Roghane Hindi in Psoriasis- A Randomised Controlled Clinical Study. - none

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/09/009681
Enrollment
70
Registered
2017-09-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients With Mild To Moderate Psoriasis

Interventions

Intervention1: Roghane-e-Hindi : Local application of the drug twice daily for three months Control Intervention1: Calcitiol Ointment.0003 micro gram/g: Local application of the drug twice daily for t

Sponsors

National Institute Of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients clinically diagnosed with mild to moderate psoriasis. 2)Patients having PASI 3 % to 20 % and PGA - mild to moderate grade

Exclusion criteria

Exclusion criteria: 1)Patients having sever psoriasis (PASI >20 % and PGA â?? severe grade) 2)Other inflammatory skin disease in the treatment area that may confound the evaluation of the psoriasis (e.g., atopic dermatitis, contact dermatitis, tinea corporis) 3)Current or past history of hypercalcemia, renal insufficiency, or hepatic disorders. 4)Patients on medication with drugs that can aggravate psoriasis like beta blockers, calcium channel blockers, or lithium. 5)Patients with any superadded infected psoriasis. 6)Pregnant or nursing (lactating) women. 7)Subject is taking or requires corticosteroids. 8)History or evidence of drug or alcohol abuse. 9)Unwilling or unable to comply with the requirements of this protocol.

Design outcomes

Primary

MeasureTime frame
Psoriasis area and severity index score(PASI)Timepoint: 03 months

Secondary

MeasureTime frame
1)Physicianâ??s static Global Assessment (sPGA) 2)Nail psoriasis index score (NAPSI) 3)Dermatology Life Quality Index (DLQI) 4)Visual analogue scale (VAS) 5)By the coloured photographs which will be taken before & after treatment (with the same magnification). Timepoint: 03 months

Countries

India

Contacts

Public ContactDr Masarat Fatima

National Institute Of Unani Medicicne

drmaquamri@gmail.com9341072974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026